Annual Shareholders Equity
$5.96 M
+$2.13 M+55.71%
31 December 2023
Summary:
Biodexa Pharmaceuticals annual stockholders equity is currently $5.96 million, with the most recent change of +$2.13 million (+55.71%) on 31 December 2023. During the last 3 years, it has fallen by -$3.20 million (-34.91%). BDRX annual shareholders equity is now -91.42% below its all-time high of $69.46 million, reached on 01 December 2015.BDRX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$11.04 M
+$5.08 M+85.23%
01 June 2024
Summary:
Biodexa Pharmaceuticals quarterly stockholders equity is currently $11.04 million, with the most recent change of +$5.08 million (+85.23%) on 01 June 2024. Over the past year, it has increased by +$4.35 million (+65.15%). BDRX quarterly shareholders equity is now -84.11% below its all-time high of $69.46 million, reached on 01 December 2015.BDRX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BDRX Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +55.7% | +65.2% |
| 3 y3 years | -34.9% | +112.5% |
| 5 y5 years | -72.3% | -64.8% |
BDRX Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -57.8% | +55.7% | -21.8% | +188.4% |
| 5 y | 5 years | -76.8% | +55.7% | -64.8% | +188.4% |
| alltime | all time | -91.4% | +375.5% | -84.1% | +188.4% |
Biodexa Pharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $11.04 M(+85.2%) |
| Dec 2023 | $5.96 M(+55.7%) | $5.96 M(-10.8%) |
| June 2023 | - | $6.68 M(+74.7%) |
| Dec 2022 | $3.83 M(-72.9%) | $3.83 M(-57.9%) |
| June 2022 | - | $9.09 M(-35.6%) |
| Dec 2021 | $14.11 M(+54.1%) | $14.11 M(+171.6%) |
| June 2021 | - | $5.19 M(-43.3%) |
| Dec 2020 | $9.16 M(-64.3%) | $9.16 M(+63.6%) |
| June 2020 | - | $5.60 M(-78.2%) |
| Dec 2019 | $25.64 M | $25.64 M(-18.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2019 | - | $31.37 M(+46.1%) |
| Dec 2018 | $21.47 M(-54.2%) | $21.47 M(-29.7%) |
| June 2018 | - | $30.56 M(-34.8%) |
| Dec 2017 | $46.86 M(-16.6%) | $46.86 M(-2.2%) |
| June 2017 | - | $47.90 M(-14.7%) |
| Dec 2016 | $56.17 M(-19.1%) | $56.17 M(+2.4%) |
| June 2016 | - | $54.83 M(-21.1%) |
| Dec 2015 | $69.46 M(+6.3%) | $69.46 M(+19.0%) |
| June 2015 | - | $58.38 M(-10.7%) |
| Dec 2014 | $65.35 M(+5115.0%) | $65.35 M |
| Dec 2013 | $1.25 M | - |
FAQ
- What is Biodexa Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Biodexa Pharmaceuticals?
- What is Biodexa Pharmaceuticals annual shareholders equity year-on-year change?
- What is Biodexa Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Biodexa Pharmaceuticals?
- What is Biodexa Pharmaceuticals quarterly shareholders equity year-on-year change?
What is Biodexa Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of BDRX is $5.96 M
What is the all time high annual shareholders equity for Biodexa Pharmaceuticals?
Biodexa Pharmaceuticals all-time high annual stockholders equity is $69.46 M
What is Biodexa Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, BDRX annual stockholders equity has changed by +$2.13 M (+55.71%)
What is Biodexa Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of BDRX is $11.04 M
What is the all time high quarterly shareholders equity for Biodexa Pharmaceuticals?
Biodexa Pharmaceuticals all-time high quarterly stockholders equity is $69.46 M
What is Biodexa Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, BDRX quarterly stockholders equity has changed by +$4.35 M (+65.15%)